How to Buy Apellis Pharmaceuticals Stock
Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases.
Apellis Pharmaceuticals stock last closed at $27.75, up 0.47% from the previous day, and has decreased 26.24% in one year. It has overperformed other stocks in the Biotechnology industry by 0.38 percentage points. Apellis Pharmaceuticals stock is currently +72.36% from its 52-week low of $16.10, and -33.83% from its 52-week high of $41.94.
There are currently 126.29M APLS shares outstanding. The market cap of APLS is $3.50B. In the last 24 hours, 3.88M APLS shares were traded.
How to Buy Apellis Pharmaceuticals Stock
Wondering how to invest in Apellis Pharmaceuticals stock? Here's how.
- Decide where to buy Apellis Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Apellis Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your investment account: Choose your payment method and add your info.
- Analyze Apellis Pharmaceuticals stock: The Apellis Pharmaceuticals ticker symbol is APLS. Is Apellis Pharmaceuticals stock a good investment? Should you buy shares of APLS? How do APLS's underlying business fundamentals look? Do top analysts think Apellis Pharmaceuticals is a good buy? Why has APLS's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if APLS is a good stock to buy).
- Execute your APLS trade: Decide if you will purchase APLS shares at the current market price or use a limit order to buy APLS shares at a given price.
- Keep tabs on your APLS position: Create a watchlist to keep tabs on your position in Apellis Pharmaceuticals stock.
Step 1: Decide where to buy Apellis Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy APLS shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you are able to buy APLS today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you have finished signing up on the best app for stock investing, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of transferring money into your new brokerage account.
Step 4: Analyze Apellis Pharmaceuticals stock
After you have selected the best place to buy Apellis Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you actually understand the risk and upside.
Overview of key APLS info
Apellis Pharmaceuticals Due Diligence Score
WallStreetZen was created to help average investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on APLS's stock page.
Is APLS stock undervalued or overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge APLS's intrinsic value.
Using relative valuations metrics:
- APLS may be overvalued based on its P/B ratio of 22.42x, relative to Biotechnology industry P/B ratio of 4.5x
You can do additional valuation analysis on APLS's stock here.
A look at APLS Cashflows and Balance Sheet
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the APLS balance sheet.
- There are more short-term assets than short-term liabilities on the APLS balance sheet.
Failed Health Checks:
- APLS has a relatively high debt to equity ratio of 4.26.
- APLS profit margin has gone up by 0.23 percentage points in the past year, but the company is still unprofitable.
- Total APLS debt is higher than 5 years ago, relative to shareholder equity.
- APLS earnings of -$180.22M is not enough to cover its interest payments.
- APLS's operating cash flow of $4.49M allows it to safely service it's debt of $469.77M.
Do analysts think it's a good time to buy Apellis Pharmaceuticals stock
Out of 17 Wall Street analysts who give ratings on APLS, the consensus analyst rating on Apellis Pharmaceuticals is a Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Latest APLS Analyst Recommendations
Colleen Kusy, a bottom 6% analyst from Baird maintains APLS with a buy rating and raises their APLS price target from $47.00 to $50.00, on Jul 18, 2025.
Tazeen Ahmad, a bottom 30% analyst from Bank of America maintains APLS with a hold rating and raises their APLS price target from $23.00 to $24.00, on Jul 16, 2025.
Judah Frommer, a bottom 6% analyst from Morgan Stanley maintains APLS with a hold rating and raises their APLS price target from $25.00 to $26.00, on Jul 2, 2025.
Derek Archila, a top 3% analyst from Wells Fargo maintains APLS with a hold rating and raises their APLS price target from $26.00 to $29.00, on Jun 2, 2025.
Graig Suvannavejh, a top 24% analyst from Mizuho maintains APLS with a hold rating and lowers their APLS price target from $30.00 to $20.00, on May 14, 2025.
You can dig deeper into what analysts are forecasting on the Apellis Pharmaceuticals stock forecast page.
APLS Technicals
Is APLS Growing Revenue?
Last year, APLS revenue was $754.65M. Over the past four year, APLS's revenue has grown by 31.64% per year. This was slower than the Biotechnology industry average of 63.27%.
Dive into APLS's earnings and revenue performance here.
What are APLS executives and large shareholders up to?
Over the last year, insiders at APLS have sold more shares than they have bought.
Cedric Francois, Chief Executive Officer of APLS, was the latest APLS insider to buy. They bought $38,777.07 worth of APLS shares on Jul 17, 2025.
Get more info about who owns APLS stock here.
Can I get consistent income from APLS stock?
No, Apellis Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other investors
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your APLS trade
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price limit, use a limit order.
Hit the Open Trade button and eToro will place your order.
If you require more help buying stocks on eToro, click the how to video below:
Step 6: Keep tabs on your APLS position
Now that you own some APLS stock, you'll want to stay up-to-date on your new investment.
Make a watchlist to track the latest developments regarding your APLS stock.
APLS Feed
How to Buy Stock in Apellis Pharmaceuticals
To reiterate, here are the 6 steps for buying Apellis Pharmaceuticals stock:
- Decide where to buy Apellis Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your investment account
- Analyze Apellis Pharmaceuticals stock
- Execute your APLS trade
- Keep tabs on your APLS position
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Apellis Pharmaceuticals, click the button below.
More Articles You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.